1. Medtech Insight
  2. >>Geography
  3. >>Europe

Medtronic Wins In England’s NICE Decision On Implantable Monitors For Stroke Patients; Biotronik And Abbott Lose

 
• By Neena Brizmohun

UK health technology assessment body NICE says that Medtronic’s Reveal LINQ, which transmits data remotely to doctors, is likely to be a cost-effective use of National Health Service resources.

Stroke_Prevention
The Reveal monitor could prevent hundreds of cryptogenic strokes • Source: Shutterstock

England’s health technology assessment body, the National Institute for Health and Care Excellence (NICE), has recommended that Medtronic’s implantable cardiac remote monitoring device, Reveal LINQ, be used routinely on the National Health Service to detect atrial fibrillation in patients who have had a cryptogenic stroke.

Rival devices from Biotronik and Abbott got the thumbs down due to a lack of necessary evidence.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United Kingdom

More from Europe